Moelis has been downgraded by UBS, with the firm's rating changed to sell. The downgrade is reportedly due to overly optimistic expectations, though there is some uncertainty regarding the adjusted price target, with one outlet indicating it was raised to $60. The move has prompted warnings of potential downside for the company.